ImmunityBio lays off 50 employees in Florida and California after bladder cancer BLA rejection
ImmunityBio has laid off 50 employees — most of them at its El Segundo, CA location — about four months after the FDA rejected its biologics license application for bladder cancer, according to notices filed in California and Florida.
According to the letter sent to the Florida Department of Economic Opportunity, ImmunityBio enacted the layoffs “to streamline operations” in order to focus on the “current business strategy and reduce costs.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.